Skip to main content
SpringerLink
Log in

PEG IFN + ribavirin can succeed where others fail in chronic HCV

  • Clinical study
  • Published:
Inpharma Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

PEG IFN + ribavirin can succeed where others fail in chronic HCV. Inpharma Wkly. 1434, 18 (2004). https://doi.org/10.2165/00128413-200414340-00050

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-200414340-00050

Keywords

Search

Navigation